drug
posaconazole DR
Marketedupdated 3mo agoby i3 Pharmaceuticals LLC
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- drugNOXAFIL POWDERMIX KIT122 co-mentions · 62 sources
- drugNOXAFIL122 co-mentions · 62 sources
- tagApproval122 co-mentions · 61 sources
- drugPOSACONAZOLE62 co-mentions · 62 sources
- tagSmall Molecule48 co-mentions · 48 sources
- company$OGNOrganon & Co.1 co-mentions · 1 sources
- companyMerck Sharp & Dohme LLC1 co-mentions · 1 sources
- tagRecall1 co-mentions · 1 sources
all catalysts(0)
nothing on the calendar yet
Trials studying posaconazole DR
- phase2A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies
- phase2Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- phase2A Study of BGB-11417 in Participants With Myeloid Malignancies
- phase3Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
- phase2Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)
- phase4Posaconazole for the Prevention of Influenza-associated Aspergillosis in Critically Ill Patients
- phase4Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell Transplants
- —Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3m ago
Found something off?
comments(0)
5-min edit window · permanent after that